Form 4 for JAGX Jaguar Health, Inc.
Accepted 2023-08-14 00:00:00 ET · period of report 2023-08-14 · accession 0001104659-23-091447 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-14 | 2023-08-14 | JAGX | CONTE LISA A | CEO, Pres, Dir | A - Grant | $0.00 | +383.6K | 387.6K | +9,590% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-14 | A | A | 383,605 | $0.00 | 387,605 | D | — | — |